Showing results (1301-1310 of 1,835) with videos related to
Sort By:
Pageof 184
Onkologie|August 1, 1985
[Therapy with inhibitors of polyamine biosynthesis in refractory prostatic carcinoma. An experimental and clinical study]U Dunzendorfer, M KnönerOnkologie|October 1, 1985
[New developments in the area of markers in diagnosis and monitoring of ovarian cancer]R Kreienberg, F MelchertOnkologie|December 9, 2008
Ewing's tumors over the age of 40: a retrospective analysis of 47 patients treated according to the International Clinical Trials EICESS 92 and EURO-E.W.I.N.G. 99Sebastian Pieper, Andreas Ranft, Gabriele Braun-Munzinger, et al.Onkologie|March 11, 2011
[Economical aspects in clinical practice: results from an explorative interview study on the perspectives of oncologists in Germany and England]Jan Schildmann, Jacinta Tan, Jochen VollmannOnkologie|July 14, 2004
Brain edema in neurooncology: radiological assessment and managementW Wick, W KükerOnkologie|February 12, 2009
Efficacy and toxicity of 153samarium-EDTMP in painful breast cancer bone metastasesJiri DolezalOnkologie|October 10, 2009
Toxic epidermal necrolysis related to pemetrexed and carboplatin with vitamin B12 and folic acid supplementation for advanced non-small cell lung cancerJoaquim Bosch-Barrera, Miren Gaztañaga, Jaime Ceballos, et al.Onkologie|October 10, 2009
Rectal intussusception due to re-recurrent ovarian fibrosarcomaInga Langner, Anne Glitsch, William Krüger, et al.Onkologie|February 1, 1991
The depot GnRH analogue goserelin in the treatment of premenopausal patients with metastatic breast cancer--a 5-year experience and further endocrine therapies. Cooperative German Zoladex Study GroupM Kaufmann, W Jonat, E Schachner-Wünschmann, et al.Onkologie|April 18, 2008
EGFR/KRAS mutations and gefitinib therapy in Chinese NSCLC patientsZhen Wang, Yi Long Wu, Guo Chun Zhang, et al.Pageof 184